NCT05383287 Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
| NCT ID | NCT05383287 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Manchester University NHS Foundation Trust |
| Condition | Heart Failure With Preserved Ejection Fraction (HFpEF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,250 participants |
| Start Date | 2022-08-12 |
| Primary Completion | 2029-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,250 participants in total. It began in 2022-08-12 with a primary completion date of 2029-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Heart failure with preserved ejection fraction (HFpEF), a certain type of heart failure, occurs when the heart doesn't pump blood around the body properly. It can cause breathlessness, tiredness, and swollen feet or ankles. It is not clear why people develop HFpEF and treatment options are very limited. TRAITS-HFpEF is a study that aims to understand why people develop HFpEF, identify new tests and treatments, and gain information on the life expectancy of people living with this condition. It will do this by routinely collecting information on people attending a specialised outpatient HFpEF clinic.
Eligibility Criteria
Inclusion Criteria: * Patients attending the HFpEF clinic at MFT. Exclusion Criteria: * Age \< 18 years * Imprisonment * Inability to provide full written or verbal informed consent in English
Contact & Investigator
Chris Miller, MBChB, MRCP
PRINCIPAL INVESTIGATOR
Manchester University NHS FT
Frequently Asked Questions
Who can join the NCT05383287 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure With Preserved Ejection Fraction (HFpEF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05383287 currently recruiting?
Yes, NCT05383287 is actively recruiting participants. Contact the research team at fardad.soltani@mft.nhs.uk for enrollment information.
Where is the NCT05383287 trial being conducted?
This trial is being conducted at Manchester, United Kingdom.
Who is sponsoring the NCT05383287 clinical trial?
NCT05383287 is sponsored by Manchester University NHS Foundation Trust. The principal investigator is Chris Miller, MBChB, MRCP at Manchester University NHS FT. The trial plans to enroll 1,250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.